Yüklüyor......
Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy
Immune checkpoint inhibitors have made rapid advances, resulting in multiple Food and Drug Administration–approved therapeutics that have markedly improved survival. However, these benefits are limited to a minority subpopulation that achieves a response. Predicting which patients are most likely to...
Kaydedildi:
| Yayımlandı: | J Nucl Med |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Society of Nuclear Medicine
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5367446/ https://ncbi.nlm.nih.gov/pubmed/27230929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.116.173930 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|